Market Ferring News Today : Breaking News, Live Updates & Top Stories | Vimarsana

/PRNewswire/ When the FDA approved Rebyota, a new class of Clostridioides Difficile (C.diff) treatment, Ferring Pharmaceuticals ushered in the first.

Scott uphamFinch pharmaceuticalsCorporate communicationsFerring pharmaceuticalsSpherix networkChallenge firstMarket ferringClostridioides difficileFecal microbiota transplantSpherix global insights market dynamixVedanta bioscienceLaunch dynamixMarket dynamixGlobal insightsSpherix global insightsFranchise leader